This inventor holds 1 USPTO granted patent. Top assignees: Changzhou Yabang Pharmaceutical Co., Ltd, Jiangsu Yabang Shengyuan Pharmaceutical Co., Ltd, Yabang Pharmaceutical Co., Ltd. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Zheng-Jun Xia: Innovator in Antibacterial Compounds
Introduction
Zheng-Jun Xia is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial agents. His work focuses on innovative compounds that have the potential to improve healthcare outcomes.
Latest Patents
Zheng-Jun Xia holds a patent for a compound known as 1,3-oxazolidine-2-one-like compound, along with its preparation method and uses. This invention provides 1,3-oxazolidin-2-one compounds of formula I and their salts, which are utilized in the preparation of linezolid racemate and its optical isomer. These compounds serve as oxazolidinone antibacterial agents, showcasing their importance in combating bacterial infections.
Career Highlights
Throughout his career, Zheng-Jun Xia has worked with prominent pharmaceutical companies, including Yabang Pharmaceutical Co., Ltd and Jiangsu Yabang Shengyuan Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to contribute to the development of innovative pharmaceutical solutions.
Collaborations
Zheng-Jun Xia has collaborated with esteemed colleagues such as Si-Qing Wang and Yong Deng. These partnerships have facilitated the advancement of research and development in the field of antibacterial compounds.
Conclusion
Zheng-Jun Xia's contributions to the field of medicinal chemistry, particularly through his patented innovations, highlight his role as a key figure in the development of effective antibacterial agents. His work continues to influence the pharmaceutical industry and improve healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile